Evolution to LPDs
| Patients . | Congenital . | Cyclic . | Autoimmune/ Idiopathic . |
|---|---|---|---|
| Female/male | 305/365 | 145/121 | 573/243 |
| Total | 670 | 266 | 816 |
| Patients evolving to LPD | |||
| Patients evolving to LPD diagnosis | 3 | 0 | 12 |
| T-cell LPD | 2 | 0 | 8 |
| Non-Hodgkin lymphoma | 1 | 0 | 3 |
| Multiple myeloma | 0 | 0 | 1 |
| Patients . | Congenital . | Cyclic . | Autoimmune/ Idiopathic . |
|---|---|---|---|
| Female/male | 305/365 | 145/121 | 573/243 |
| Total | 670 | 266 | 816 |
| Patients evolving to LPD | |||
| Patients evolving to LPD diagnosis | 3 | 0 | 12 |
| T-cell LPD | 2 | 0 | 8 |
| Non-Hodgkin lymphoma | 1 | 0 | 3 |
| Multiple myeloma | 0 | 0 | 1 |
LPD, lymphoproliferative disease.